vs
Side-by-side financial comparison of Good Times Restaurants Inc. (GTIM) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Good Times Restaurants Inc. is the larger business by last-quarter revenue ($32.7M vs $28.1M, roughly 1.2× ARS Pharmaceuticals, Inc.). Good Times Restaurants Inc. runs the higher net margin — 0.6% vs -147.1%, a 147.7% gap on every dollar of revenue. On growth, Good Times Restaurants Inc. posted the faster year-over-year revenue change (-10.0% vs -67.6%).
Good Times is a Golden, Colorado–based fast-food restaurant specializing in premium burgers and frozen custard. As of July 2023, the chain operates 31 locations, down from 38 in 2015.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
GTIM vs SPRY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.7M | $28.1M |
| Net Profit | $181.0K | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | 0.9% | -147.6% |
| Net Margin | 0.6% | -147.1% |
| Revenue YoY | -10.0% | -67.6% |
| Net Profit YoY | 10.4% | -182.8% |
| EPS (diluted) | $0.02 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.7M | $28.1M | ||
| Q3 25 | $37.0M | $32.5M | ||
| Q2 25 | $34.3M | $15.7M | ||
| Q1 25 | — | $8.0M | ||
| Q4 24 | $36.3M | $86.6M | ||
| Q3 24 | $35.8M | $2.1M | ||
| Q2 24 | $38.0M | $500.0K | ||
| Q1 24 | $35.4M | $0 |
| Q4 25 | $181.0K | $-41.3M | ||
| Q3 25 | $1.5M | $-51.2M | ||
| Q2 25 | $-624.0K | $-44.9M | ||
| Q1 25 | — | $-33.9M | ||
| Q4 24 | $164.0K | $49.9M | ||
| Q3 24 | $230.0K | $-19.1M | ||
| Q2 24 | $1.3M | $-12.5M | ||
| Q1 24 | $618.0K | $-10.3M |
| Q4 25 | 0.9% | -147.6% | ||
| Q3 25 | 3.3% | -163.7% | ||
| Q2 25 | -1.5% | -302.9% | ||
| Q1 25 | — | -466.3% | ||
| Q4 24 | 0.2% | 54.5% | ||
| Q3 24 | -0.3% | -1051.6% | ||
| Q2 24 | 3.2% | -3068.0% | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 0.6% | -147.1% | ||
| Q3 25 | 4.0% | -157.4% | ||
| Q2 25 | -1.8% | -285.6% | ||
| Q1 25 | — | -425.7% | ||
| Q4 24 | 0.5% | 57.7% | ||
| Q3 24 | 0.6% | -925.0% | ||
| Q2 24 | 3.5% | -2503.2% | ||
| Q1 24 | 1.7% | — |
| Q4 25 | $0.02 | $-0.41 | ||
| Q3 25 | $0.14 | $-0.52 | ||
| Q2 25 | $-0.06 | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | $0.02 | $0.52 | ||
| Q3 24 | $0.01 | $-0.20 | ||
| Q2 24 | $0.12 | $-0.13 | ||
| Q1 24 | $0.06 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $33.2M | $114.3M |
| Total Assets | $82.5M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $245.0M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | $2.7M | $240.1M | ||
| Q1 25 | — | $275.7M | ||
| Q4 24 | $3.0M | $314.0M | ||
| Q3 24 | $3.9M | $204.6M | ||
| Q2 24 | — | $218.7M | ||
| Q1 24 | $4.0M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $33.2M | $114.3M | ||
| Q3 25 | $33.1M | $147.7M | ||
| Q2 25 | $31.6M | $192.3M | ||
| Q1 25 | — | $229.0M | ||
| Q4 24 | $32.4M | $256.8M | ||
| Q3 24 | $32.4M | $201.0M | ||
| Q2 24 | $32.3M | $215.2M | ||
| Q1 24 | $31.6M | $223.9M |
| Q4 25 | $82.5M | $327.7M | ||
| Q3 25 | $85.8M | $372.8M | ||
| Q2 25 | $86.9M | $313.5M | ||
| Q1 25 | — | $327.3M | ||
| Q4 24 | $89.5M | $351.2M | ||
| Q3 24 | $87.1M | $217.6M | ||
| Q2 24 | $90.1M | $222.0M | ||
| Q1 24 | $89.0M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $-43.5M |
| Free Cash FlowOCF − Capex | $1.2M | — |
| FCF MarginFCF / Revenue | 3.8% | — |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.85× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-72.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $-43.5M | ||
| Q3 25 | $1.3M | $-47.0M | ||
| Q2 25 | $714.0K | $-39.6M | ||
| Q1 25 | — | $-40.7M | ||
| Q4 24 | $-518.0K | $42.0M | ||
| Q3 24 | $394.0K | $-14.5M | ||
| Q2 24 | $3.2M | $-7.3M | ||
| Q1 24 | $1.8M | $-6.7M |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $735.0K | $-47.2M | ||
| Q2 25 | $-105.0K | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | $-1.9M | $41.7M | ||
| Q3 24 | $-466.0K | $-14.6M | ||
| Q2 24 | $2.0M | $-7.3M | ||
| Q1 24 | $1.2M | $-6.8M |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.0% | -145.4% | ||
| Q2 25 | -0.3% | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | -5.3% | 48.2% | ||
| Q3 24 | -1.3% | -706.3% | ||
| Q2 24 | 5.3% | -1463.4% | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 1.4% | 0.6% | ||
| Q2 25 | 2.4% | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | 3.9% | 0.3% | ||
| Q3 24 | 2.4% | 6.8% | ||
| Q2 24 | 3.2% | 7.6% | ||
| Q1 24 | 1.7% | — |
| Q4 25 | 7.85× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.16× | 0.84× | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 2.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GTIM
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
